Cargando…

Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease

Atherosclerosis is the leading cause of death worldwide, especially in patients with type 2 diabetes mellitus (T2D). GLP-1 receptor agonists and DPP-4 inhibitors were demonstrated to play a markedly protective role for the cardiovascular system beyond their glycemic control. Several cardiovascular o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernardini, Federico, Nusca, Annunziata, Coletti, Federica, La Porta, Ylenia, Piscione, Mariagrazia, Vespasiano, Francesca, Mangiacapra, Fabio, Ricottini, Elisabetta, Melfi, Rosetta, Cavallari, Ilaria, Ussia, Gian Paolo, Grigioni, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386670/ https://www.ncbi.nlm.nih.gov/pubmed/37514043 http://dx.doi.org/10.3390/pharmaceutics15071858

Ejemplares similares

Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study
por: Nusca, Annunziata, et al.
Publicado: (2021)

Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data
por: Nusca, Annunziata, et al.
Publicado: (2022)

The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA)
por: Mangiacapra, Fabio, et al.
Publicado: (2021)

Invasive Assessment of Coronary Microvascular Function
por: Mangiacapra, Fabio, et al.
Publicado: (2021)

Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets
por: Piccirillo, Francesco, et al.
Publicado: (2023)

Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention
por: Nusca, Annunziata, et al.
Publicado: (2019)

Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease
por: Nusca, Annunziata, et al.
Publicado: (2021)

Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned?
por: Cocco, Nino, et al.
Publicado: (2023)

Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality—A Comprehensive Review
por: Piccirillo, Francesco, et al.
Publicado: (2023)

Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies
por: Paolucci, Luca, et al.
Publicado: (2022)

In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches
por: Nusca, Annunziata, et al.
Publicado: (2022)

Percutaneous Repair of Atrial Functional Tricuspid Regurgitation in Cardiac Amyloidosis: Combining Linear With Lateral Thinking
por: Nusca, Annunziata, et al.
Publicado: (2022)

Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study
por: Nusca, Annunziata, et al.
Publicado: (2015)

Game Changers
Publicado: (2014)

Game Changers
Publicado: (2014)

Game Changers
Publicado: (2015)

Game Changers
Publicado: (2015)

Game changers
Publicado: (2016)

Understanding the Cardiovascular Effects of Incretin
por: Yoon, Ji Sung, et al.
Publicado: (2011)

SDF − a game changer?
por: Remtulla, A.
Publicado: (2020)

Functional Mitral and Tricuspid Regurgitation across the Whole Spectrum of Left Ventricular Ejection Fraction: Recognizing the Elephant in the Room of Heart Failure
por: Cammalleri, Valeria, et al.
Publicado: (2023)

Digital health: a game changer
Publicado: (2019)

Intelligentes Wissensmanagement als Game Changer
por: Fallmann, Daniel
Publicado: (2021)

Das Virus als Game Changer
por: Vollrath, Fabian
Publicado: (2021)

Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review
por: Liarakos, Alexandros Leonidas, et al.
Publicado: (2023)

Game changers: stories of the revolutionary minds behind game theory
por: Taschner, Rudolf
Publicado: (2017)

Dexmedetomidine: The game changer or a team player?
por: Goyal, Rakhee
Publicado: (2016)

Reflecting on ICN2: was it a game changer?
por: Brinsden, Hannah, et al.
Publicado: (2015)

IMMUNOTHERAPY FOR LUNG CANCER – A GAME CHANGER!
por: Walls, GM, et al.
Publicado: (2017)

Metagenomics: The Next Culture-Independent Game Changer
por: Forbes, Jessica D., et al.
Publicado: (2017)

Commentary: Artificial intelligence–A game changer
por: Ahuja, Ashish, et al.
Publicado: (2020)

Transoral Thyroidectomy: Is It a Real Game Changer?
por: Tae, Kyung
Publicado: (2020)

Flu RNA Vaccine: A Game Changer?
por: Meurens, François
Publicado: (2020)

Editorial: Game Changers in Inflammatory Bowel Diseases
por: Bálint, Anita, et al.
Publicado: (2021)

Plasmodium knowlesi: the game changer for malaria eradication
por: Lee, Wenn-Chyau, et al.
Publicado: (2022)

Refractive surgery – the 20/happy game changer
por: Honavar, Santosh G
Publicado: (2020)

Tricuspid Valve Geometrical Changes in Patients with Functional Tricuspid Regurgitation: Insights from a CT Scan Analysis Focusing on Commissures
por: Cammalleri, Valeria, et al.
Publicado: (2023)

Human core duplicon gene families: game changers or game players?
por: Bekpen, Cemalettin, et al.
Publicado: (2019)

The Influence of Incretin Mimetics on Cardiovascular Risk Factors in Diabetes
por: Kinalska, Ida, et al.
Publicado: (2012)

Incretins and cardiovascular disease: to the heart of type 2 diabetes?
por: Solini, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8l4cguajc2ba5usu3rpnmms4u0